TITAN PHARMACEUTICALS INC reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
San Francisco, CA
SEC filing record 1 source field available
Fiscal year end
31 December
TITAN PHARMACEUTICALS INC has filed 1,052 SEC EDGAR filings since 15 May 1996

SEC filing history

Showing 576-600 of 686 matching filings.

Per page
25
Current page
24
SC 13G/A File 005-46083

SC 13G/A filing

Filing date
14 Feb 2013
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-46083

SC 13G/A filing

Filing date
11 Feb 2013
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-27436

FORM 8-K

Filing date
07 Feb 2013
Reporting date
06 Feb 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-27436

FORM 8-K

Filing date
07 Jan 2013
Reporting date
07 Jan 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-27436

FORM 8-K

Filing date
03 Jan 2013
Reporting date
31 Dec 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-27436

FORM 8-K

Filing date
02 Jan 2013
Reporting date
31 Dec 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-27436

FORM 8-K

Filing date
19 Dec 2012
Reporting date
14 Dec 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-27436

FORM 8-K

Filing date
31 Oct 2012
Reporting date
29 Oct 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-27436

FORM 8-K

Filing date
16 Oct 2012
Reporting date
13 Oct 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-27436

FORM 8-K

Filing date
11 Oct 2012
Reporting date
08 Oct 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-27436

FORM 8-K

Filing date
14 Sep 2012
Reporting date
12 Sep 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
424B3 File 333-166351

FILED PURSUANT TO RULE 424(B)(3)

Filing date
24 May 2012
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-27436

FORM 8-K

Filing date
17 Apr 2012
Reporting date
16 Apr 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
424B5 File 333-178656

PROSPECTUS SUPPLEMENT

Filing date
11 Apr 2012
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-27436

FORM 8-K

Filing date
10 Apr 2012
Reporting date
09 Apr 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
EFFECT File 333-166351

EFFECT filing

Filing date
05 Apr 2012
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
POS AM File 333-166351

POST-EFFECTIVE AMENDMENT NO. 3 TO FORM S-1 REGISTRATION STATEMENT

Filing date
23 Mar 2012
Reporting date
Not listed
Next action
Verify source filing
10-K/A File 000-27436

AMENDMENT NO. 1 TO FORM 10-K

Filing date
23 Mar 2012
Reporting date
31 Dec 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-46083

SC 13G/A filing

Filing date
14 Feb 2012
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-27436

FORM 8-K

Filing date
10 Feb 2012
Reporting date
09 Feb 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-46083

SC 13G filing

Filing date
07 Feb 2012
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .